Correlation Between Dominari Holdings and Lumos Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and Lumos Pharma, you can compare the effects of market volatilities on Dominari Holdings and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Lumos Pharma.

Diversification Opportunities for Dominari Holdings and Lumos Pharma

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dominari and Lumos is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Lumos Pharma go up and down completely randomly.

Pair Corralation between Dominari Holdings and Lumos Pharma

Given the investment horizon of 90 days Dominari Holdings is expected to generate 1.29 times less return on investment than Lumos Pharma. In addition to that, Dominari Holdings is 1.18 times more volatile than Lumos Pharma. It trades about 0.04 of its total potential returns per unit of risk. Lumos Pharma is currently generating about 0.06 per unit of volatility. If you would invest  393.00  in Lumos Pharma on September 3, 2024 and sell it today you would earn a total of  37.00  from holding Lumos Pharma or generate 9.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dominari Holdings  vs.  Lumos Pharma

 Performance 
       Timeline  
Dominari Holdings 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak primary indicators, Dominari Holdings may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Lumos Pharma 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lumos Pharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady primary indicators, Lumos Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dominari Holdings and Lumos Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dominari Holdings and Lumos Pharma

The main advantage of trading using opposite Dominari Holdings and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.
The idea behind Dominari Holdings and Lumos Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges